118 related articles for article (PubMed ID: 2385876)
1. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984).
Lloyd-Davies RW; Collins CD; Swan AV
Urology; 1990 Aug; 36(2):107-11. PubMed ID: 2385876
[TBL] [Abstract][Full Text] [Related]
2. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique.
Collins CD; Lloyd-Davies RW; Swan AV
Clin Oncol (R Coll Radiol); 1991 May; 3(3):127-32. PubMed ID: 2069876
[TBL] [Abstract][Full Text] [Related]
3. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.
Perez CA; Hanks GE; Leibel SA; Zietman AL; Fuks Z; Lee WR
Cancer; 1993 Dec; 72(11):3156-73. PubMed ID: 7694785
[TBL] [Abstract][Full Text] [Related]
4. [High dosage brachytherapy and external irradiation of localized prostate carcinoma--results at the Kiel University Clinic].
Kovács G; Galalae R; Loch T; Rzehak P; Wilhelm R; Bertermann H; Nürnberg N; Kohr P; Kimmig B
Praxis (Bern 1994); 2001 Sep; 90(38):1617-22. PubMed ID: 11675914
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987.
Hahn P; Baral E; Cheang M; Math MC; Kostyra J; Roelss R
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):41-7. PubMed ID: 12118564
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
[TBL] [Abstract][Full Text] [Related]
10. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate.
Rosser CJ; Levy LB; Kuban DA; Chichakli R; Pollack A; Lee A; Pisters LL
J Urol; 2003 Jun; 169(6):2160-5. PubMed ID: 12771739
[TBL] [Abstract][Full Text] [Related]
11. High-dose radiotherapy for localized prostatic cancer. An analysis of treatment results and early complications.
Kearsley JH
Med J Aust; 1986 Jun; 144(12):624-8. PubMed ID: 3086680
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy of localized prostatic carcinoma].
Gez E; Netzer-Horowitz Y; Waiman E; Rubinov R; Cohen Y; Kuten A
Harefuah; 1997 Dec; 133(12):593-6, 664. PubMed ID: 9451865
[TBL] [Abstract][Full Text] [Related]
13. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in prostatic carcinoma treated with radical radiotherapy: stages A, B, and C].
Rodríguez Villalba S; Magallón Sebastián R; Regueiro Otero C; Rodríguez Reina G; Romero Fernández J; Carballido Rodríguez J; De la Torre Tomás A; Aragón de la Cruz G
Actas Urol Esp; 1996 Apr; 20(4):336-45. PubMed ID: 8801794
[TBL] [Abstract][Full Text] [Related]
15. Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.
Vance SM; Stenmark MH; Blas K; Halverson S; Hamstra DA; Feng FY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):940-6. PubMed ID: 22056069
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation.
Critz FA; Tarlton RS; Holladay DA
Cancer; 1995 May; 75(9):2383-91. PubMed ID: 7536126
[TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
[TBL] [Abstract][Full Text] [Related]
19. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
Zelefsky MJ; Marion C; Fuks Z; Leibel SA
J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
[TBL] [Abstract][Full Text] [Related]
20. Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1449-72. PubMed ID: 11037559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
